We are live on ! Find out more
ECM

Elgethun Capital Management Portfolio holdings

AUM $718M
1-Year Est. Return 18.6%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+18.6%
3 Year Est. Return
+61.47%
5 Year Est. Return
+71.42%
10 Year Est. Return
–
AUM
$397M
AUM Growth
+$43.4M
Cap. Flow
+$17.7M
Cap. Flow %
4.47%
Top 10 Hldgs %
46.7%
Holding
157
New
3
Increased
70
Reduced
33
Closed
1

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$8.27M
2
LBTYK icon
Liberty Global Class C
LBTYK
+$3.06M
3
BOC icon
Boston Omaha
BOC
+$2.01M
4
GLD icon
SPDR Gold Trust
GLD
+$678K
5
MRK icon
Merck
MRK
+$644K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$512K
2
FFH
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
+$266K
3
BATRK icon
Atlanta Braves Holdings Series B
BATRK
+$155K
4
DFH icon
Dream Finders Homes
DFH
+$148K
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$127K

Sector Composition

Rank Sector Weight
1 Financials 33.57%
2 Consumer Discretionary 8.7%
3 Healthcare 8.12%
4 Communication Services 6.3%
5 Technology 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCTX icon
151
Lineage Cell Therapeutics
LCTX
$278M
$21.5K 0.01%
15,000
– –
NGD
152
DELISTED
New Gold Inc
NGD
$20.7K 0.01%
12,000
– –
OPFI.WS
153
DELISTED
OppFi Inc Warrants
OPFI.WS
$10.8K ﹤0.01%
134,700
– –
BHIL
154
DELISTED
Benson Hill, Inc.
BHIL
$3.13K ﹤0.01%
457
– –
SABS icon
155
SAB Biotherapeutics
SABS
$355M
– –
-544
Closed -$6.47K
3 4 5 6
7

Similar funds

TFA
Tobias Financial Advisors Plantation, Florida $718M AUM 15.66% 1-Year Est. Return
KC
Kadensa Capital Central, Hong Kong $718M AUM 38.33% 1-Year Est. Return
EI
Ellevest Inc New York $719M AUM 23.17% 1-Year Est. Return
CFO
Cambient Family Office Ada, Michigan $716M AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return

Elgethun Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Elgethun Capital Management held 157 positions worth $397M, up 12% from $353M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Elgethun Capital Management deployed $17.7M of net new capital in Q1 2024, opening 3 new positions and adding to 70 existing holdings. Its largest new stake was SPDR Gold Trust: 3,531 shares worth $732K.

By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $512K trimmed.

  • Elgethun Capital Management's largest Q1 2024 buy was SPDR Gold Trust: 3,531 shares worth $732K.
  • Elgethun Capital Management added most to Eli Lilly in Q1 2024, an estimated $8.27M increase.
  • Elgethun Capital Management's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $512K.
  • Elgethun Capital Management fully exited SAB Biotherapeutics in Q1 2024, selling an estimated $6.47K.
  • Elgethun Capital Management's ten largest holdings make up 47% of its $397M portfolio in Q1 2024.
  • Elgethun Capital Management opened 3 new positions and closed 1 in Q1 2024.
  • Elgethun Capital Management's portfolio value rose 12% quarter-over-quarter to $397M.

Based on Elgethun Capital Management's 13F filing for Q1 2024, filed 14 May 2024.